COVID-19 Miniseries Episode 26: Mayo Clinic Q&A - Atypical Kawasaki Disease, Recombination Events, and Antiviral Therapy Updates
Published May 12, 2020
|
15 min
    Download
    Add to queue
    Copy URL
    Show notes
    This episode is shared from Mayo Clinic Q&A and was recorded in May 2020.To claim credit visit https://ce.mayo.edu/covid19podcastGuest:  Gregory Poland, M.D. (@drgregpoland)Host: Halena M. Gazelka, M.D. (@hmgazelkamd)On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic’s Vaccine Research Group, discusses how SARS-CoV-2 is mutating, atypical Kawasaki disease emerging in pediatric patients, updates in antiviral therapies and how scientists and researchers are rapidly gaining new knowledge about the virus and the disease that it causes.AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
      15
      15
        0:00:00 / 0:00:00